Duopharma Biotech Berhad (KLSE:DPHARMA)

Malaysia · Delayed Price · Currency is MYR

1.490

+0.020 (1.36%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Manufacturing and Distribution of Pharmaceutical Products	813.70M	704.73M	696.72M	639.18M	569.90M
Manufacturing and Distribution of Pharmaceutical Products Growth	15.46%	1.15%	9.00%	12.16%	-1.14%
Total	813.70M	704.73M	696.72M	639.18M	569.90M
Total Growth	15.46%	1.15%	9.00%	12.16%	-1.14%

Revenue by Geography

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Malaysia	754.18M	650.55M	654.89M	596.89M	525.43M
Malaysia Growth	15.93%	-0.66%	9.72%	13.60%	-0.97%
Export	59.51M	54.18M	41.83M	42.29M	44.48M
Export Growth	9.84%	29.53%	-1.09%	-4.92%	-3.12%
Total	813.70M	704.73M	696.72M	639.18M	569.90M
Total Growth	15.46%	1.15%	9.00%	12.16%	-1.14%

Source: S&P Global Market Intelligence.